Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research

Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx

News
Published on:
September 5, 2022

Alira Health, a global health care consulting, research, and technology company, and Legit.Health, a leading next generation clinical data tool focused on dermatology, announced a partnership that offers patients the opportunity to be involved in the research and development of dermatology solutions. This approach reduces complexity for pharma, biotech and medtech companies while meeting the expectations of regulators, providers, and payers.

In partnership with Legit.Health, we are pleased to offer next generation dermatology solutions that increase recruitment rates, show better compliance, lower drop-out rates, and reduce complexity in clinical operations.”
Benjamin Chambon Chief Commercial Officer, Alira Health

The Alira Health and Legit.Health partnership extends Alira Health’s scalable digital health ecosystem with Legit.Health’s clinically validated AI-based dermatology image assessment neural networks to automate Patient Reported Outcomes (PRO) through a simple smartphone camera image. This combination is designed to automate the verification of inclusion criteria, automate participant monitoring and clinical endpoint acquisition and recruitment, and increase the diversity of participants. Companies can leverage this for dermatology Decentralized Clinical Trials (DCT), Real-World Evidence (RWE), and Digital Therapeutics (DTx).

Legit.Health’s technology allows Alira Health to automatically fill in most scoring system for dermatological conditions, with improved reliability, lower variability, and a fraction of the time an effort. Scoring systems such as EASI, SCORAD, PASI, IHS4 constitute the backbone of dermatology clinical trials, but they are also their biggest weakness and are tedious for researchers. This partnership will enable sponsors to speed up clinical trials and increase reliability of clinical endpoints thanks to automatically filling in scoring system through clinical images.

“Today, dermatology study sponsors face increasing complexity in clinical trial design and execution,” said Benjamin Chambon, Chief Commercial Officer of Alira Health. “Trial recruitment remains challenging, trial operations are more dispersed, protocol adherence issues are more prevalent, and protocol processes for standardizing data collection now include specifications for photography and high-resolution video communication. In partnership with Legit.Health, we are pleased to offer next generation dermatology solutions that increase recruitment rates, show better compliance, lower drop-out rates, and reduce complexity in clinical operations.”

“Pharma cannot make drugs of the future using tools of the past”, said Taig Mac Carthy, Founder and CEO of Legit.Health. “Legit.Health‘s artificial intelligence allows you to screen for 302 different pathologies, providing the most probable diagnosis, measuring the severity of the disease and even checking for the quality of the image. Our advanced dermatology technology combined with Alira Health’s cutting-edge approach to digital health solutions is a game-changer for the industry.”

Contact us to learn more or meet up at the EADV Congress in Milan this week!

Related news

Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Events September 6, 2022
EADV Congress 2022
We are pleased to share that our team will be attending EADV Congress 2022 in Milan this September. EADV Congress is an outstanding educational and learning experience for dermatologists(...)
Decentralized Clinical Trials Digital Therapeutics Real-World Evidence
News September 5, 2022
Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research
Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx.
Decentralized Clinical Trials Dermatology DTx RWE
Events August 25, 2022
Outsourcing in Clinical Trials Southern California 2022
Join us in San Diego on September 28th and 29th and learn about the unparalleled support and value we can offer at every stage of your corporate and product evolution.
Decentralized Clinical Trials Hybrid Clinical Trials Outsourcing Clinical Trials
News August 17, 2022
Alira Health Joins the IRB Barcelona to Advance the Development of Personalized Cancer Treatments
We are pleased to announce we are joining the Institute for Research in Biomedicine (IRB Barcelona) as part of the CGI-Clinics project.
Patient Centric Real-World Evidence RWE
Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Multimedia August 1, 2022
Partners in the Continuum of Drug Development
Listen to the new Empowered Patient Podcast with Karen Jagoda as Gabriele Brambilla, Alira Health CEO, discusses novel approach using technology services to actively engage and partner(...)
Decentralized Clinical Trials Digital Health Patient Centric
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.